Systemic inflammation, endothelial dysfunction and coagulopathy are of high clinical
relevance in the management of people living with HIV (PLWH), and even more in patients …

Objectives: Immune dysregulation is a hallmark of HIV and hepatitis C virus (HCV)
infections. We aimed to evaluate the relationship between liver stiffness measurement (LSM) …

(1) Background: The role of hepatitis C virus (HCV) co-infection on the T-cell homeostasis
disturbances in human immunodeficiency virus (HIV)-infected patients as well as its …

The objective of this work was to identify predictive factors of fibrosis regression after direct
antiviral agents (DAAs) in HCV-monoinfected and HIV/HCV-coinfected patients. This was a …

Objectives The aim of the study was to assess the regression of liver stiffness after
successful direct‐acting antiviral (DAA) treatment in patients with hepatitis C virus (HCV) …

Background Some people living with hepatitis C virus (HCV) with sustained virological
response (SVR) develop hepatic complications. Liver stiffness (LS) predicts clinical outcome …

Objectives Only a few studies have addressed liver stiffness dynamics after hepatitis C virus
(HCV) treatment in patients with HIV/HCV coinfection. The aim was to evaluate the variation …

Objective We assessed the impact of a sustained virological response (SVR) on liver
stiffness among HIV/hepatitis C virus (HCV)-coinfected patients enrolled in the ANRS CO13 …

Background: Advanced cirrhosis is related to alterations in immunity. We aimed to evaluate
the levels of peripheral CD4+ T cells (Tregs) and plasma cytokine in patients coinfected with …

Background: Eradication of hepatitis C virus (HCV) promotes an improvement in liver
disease and the deactivation of the immune system. Here, we aimed to evaluate the …